Cromoglicic acid

Hypersensitivity.

Lactation, cardiac arrhythmias, hepatic or renal dysfunction.

Nausea, headache, dizziness, unpleasant taste, joint pain and swelling, skin rashes, aggravation of asthma, pulmonary infiltrates with eosinophilia, urticaria. Bronchospasm, wheezing, cough, nasal congestion and throat irritation following inhalation of dry powder. Intranasal use: Transient irritation of nasal mucosa. Sneezing and epistaxis (occasional). Eye drops: Transient burning and stinging.

Antiasthmatic & COPD Preparations / Nasal Decongestants & Other Nasal Preparations / Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories

D11AH03 - cromoglicic acid ; Belongs to the class of agents for atopic dermatitis, excluding corticosteroids. Used in the treatment of atopic dermatitis.
A07EB01 - cromoglicic acid ; Belongs to the class of antiallergic antiinflammatory, excluding corticosteroids. Used in the treatment of intestinal inflammation.
R01AC01 - cromoglicic acid ; Belongs to the class of topical antiallergic preparations, excluding corticosteroids. Used as antiallergic agents.
S01GX01 - cromoglicic acid ; Belongs to the class of other ophthalmologic antiallergics.
R03BC01 - cromoglicic acid ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, antiallergic agents.